Comparing Treatment Options for Peripheral Arterial Disease (PAD)
Peripheral Arterial Disease (PAD) is a chronic circulatory condition characterized by the narrowing of arteries, most commonly in the legs, which reduces blood flow to the limbs [1]. This reduction in blood supply can lead to pain, numbness, or cramping, particularly during exercise, a symptom known as claudication [2]. PAD is a significant global health concern, affecting over 200 million individuals worldwide [3]. In the United States alone, estimates suggest that at least 21 million people currently live with PAD, with projections indicating this number could exceed 26 million [4]. The prevalence of PAD increases sharply with age, affecting more than 10% of individuals in their 60s and 70s [5].
Several factors contribute to the development and progression of PAD. The primary risk factor is smoking, which significantly increases an individual's susceptibility to the disease [6]. Other major risk factors include diabetes mellitus, hyperlipidemia (high cholesterol), hypertension (high blood pressure), and chronic kidney disease [7]. These conditions contribute to atherosclerosis, the hardening and narrowing of arteries due to plaque buildup, which is the underlying cause of most PAD cases [1].
Symptoms of PAD can vary in severity and may include painful muscle cramping in the hips, thighs, or calves during activity, leg numbness or weakness, coldness in the lower leg or foot, sores on the toes, feet, or legs that do not heal, a change in the color of the legs, hair loss on the legs, and slow-growing toenails [2]. In some cases, PAD may be asymptomatic, making early detection challenging. Diagnosis often involves a physical examination, review of symptoms, and a simple, non-invasive test called the ankle-brachial index (ABI), which compares blood pressure in the ankle to blood pressure in the arm [8]. Early and accurate diagnosis is crucial for effective management and to prevent severe complications, including limb loss.
II. Overview of PAD Treatment Goals
The management of Peripheral Arterial Disease (PAD) is multifaceted, aiming to achieve several critical objectives that collectively enhance patient well-being and long-term health outcomes. The primary goals of PAD treatment include alleviating symptoms, preventing the progression of the disease, reducing the risk of major cardiovascular events such as heart attack and stroke, and improving the overall quality of life for affected individuals [1, 9].
**Symptom Alleviation:** A key immediate goal is to manage and reduce symptoms, particularly intermittent claudication (leg pain during exercise), which can significantly impair mobility and daily activities. Effective symptom control allows patients to engage in more physical activity, which is crucial for improving circulation and overall cardiovascular health [1].
**Prevention of Disease Progression:** Beyond symptom management, treatment strategies focus on halting or slowing the advancement of atherosclerosis, the underlying cause of PAD. This involves addressing and modifying risk factors to prevent further narrowing of the arteries and to preserve limb function [7].
**Reduction of Cardiovascular Event Risk:** Patients with PAD are at a significantly higher risk of experiencing cardiovascular events, including heart attack, stroke, and cardiovascular death [9]. Therefore, a major treatment objective is to aggressively manage systemic risk factors to mitigate these life-threatening complications [9].
**Improvement of Quality of Life:** Ultimately, the goal of PAD treatment extends to improving the patient's overall quality of life. This encompasses enhancing their ability to walk without pain, increasing their functional independence, and reducing the psychological burden associated with chronic disease [10]. Individualized chronic disease management is central to achieving this goal [11].
III. Lifestyle Modifications
Lifestyle modifications form the cornerstone of Peripheral Arterial Disease (PAD) management, often serving as the initial and most crucial step in alleviating symptoms and slowing disease progression [12]. These changes are fundamental for all PAD patients, regardless of disease severity, and are often implemented in conjunction with other treatment modalities.
**A. Smoking Cessation:** Smoking is unequivocally the most significant modifiable risk factor for PAD, contributing to its development and accelerating its progression [6, 13]. Quitting smoking is the single most impactful action a PAD patient can take to improve their prognosis. Studies show that PAD patients who cease smoking can significantly slow the progression of the disease, reduce the risk of cardiovascular events, and improve overall well-being [14, 15]. Comprehensive smoking cessation programs, including counseling and pharmacotherapy, are highly recommended to support patients in this critical endeavor [16].
**B. Regular Exercise (Supervised Exercise Programs):** Regular physical activity, particularly supervised exercise programs (SEPs), is a highly effective non-invasive treatment for PAD, especially for patients experiencing intermittent claudication [12]. SEPs typically involve treadmill-based walking exercises performed three times per week for a structured duration, often in a cardiovascular rehabilitation setting [17, 18]. This type of exercise improves walking distance, reduces pain, and enhances quality of life by promoting collateral circulation and improving endothelial function [19]. Patients are encouraged to walk to the point of moderate pain, rest, and then resume walking, gradually increasing their endurance over time.
**C. Dietary Changes:** Adopting a heart-healthy diet is vital for managing PAD and its associated risk factors. This typically involves a diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, while limiting saturated and trans fats, cholesterol, sodium, and refined sugars [20]. Diets such as the Mediterranean Diet and the DASH (Dietary Approaches to Stop Hypertension) diet are often recommended for their proven benefits in cardiovascular health [20]. These dietary interventions help to manage blood pressure, cholesterol levels, and blood glucose, thereby reducing the atherosclerotic burden.
**D. Weight Management:** Maintaining a healthy weight or achieving weight loss if overweight or obese is crucial for PAD patients. Excess weight places additional strain on the cardiovascular system and can exacerbate risk factors such as hypertension, diabetes, and dyslipidemia [12]. Weight management, often achieved through a combination of dietary changes and increased physical activity, can lead to significant improvements in PAD symptoms and overall cardiovascular health.
IV. Medical Management
Medical management plays a crucial role in treating Peripheral Arterial Disease (PAD), focusing on controlling risk factors, alleviating symptoms, and preventing cardiovascular complications. Pharmacological interventions are often used in conjunction with lifestyle modifications to achieve optimal patient outcomes [21].
**A. Antiplatelet Medications:** Antiplatelet therapy is a cornerstone of PAD treatment, primarily aimed at preventing blood clots that can worsen arterial narrowing and lead to serious cardiovascular events. Low-dose aspirin is commonly prescribed to reduce the risk of myocardial infarction and stroke [22]. Clopidogrel is another antiplatelet agent that may be used, particularly in patients who cannot tolerate aspirin or in specific high-risk scenarios [23]. These medications work by inhibiting platelet aggregation, thereby reducing the formation of thrombi in the diseased arteries [22].
**B. Cholesterol-Lowering Medications (Statins):** Statins are highly effective in managing dyslipidemia, a significant risk factor for atherosclerosis and PAD. These medications lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, which helps to stabilize existing plaque, prevent new plaque formation, and reduce the risk of cardiovascular events [24]. Current guidelines recommend statin therapy for all individuals with PAD, regardless of their baseline cholesterol levels, due to their proven cardiovascular protective benefits [25, 26].
**C. Blood Pressure Medications:** Hypertension is a common comorbidity in PAD patients and contributes to disease progression. Controlling blood pressure is essential to reduce the strain on the cardiovascular system and minimize the risk of heart attack, stroke, and kidney disease. Various antihypertensive medications, such as ACE inhibitors, ARBs, beta-blockers, and diuretics, may be used to achieve target blood pressure levels, tailored to individual patient needs and other medical conditions [21].
**D. Medications for Symptom Relief (e.g., Cilostazol):** For patients experiencing intermittent claudication, specific medications can help alleviate symptoms and improve walking ability. Cilostazol is a phosphodiesterase inhibitor that increases blood flow to the limbs and reduces platelet aggregation, thereby improving walking distance and quality of life in some PAD patients [27]. Pentoxifylline is another medication that has been used, though its efficacy is generally considered less robust than cilostazol [21].
**E. Diabetes Management:** Diabetes mellitus is a major risk factor for PAD and can significantly worsen its prognosis. Strict control of blood glucose levels is paramount in diabetic PAD patients to prevent further microvascular and macrovascular complications. This involves a combination of dietary management, regular exercise, and antidiabetic medications, including insulin if necessary [21].
V. Endovascular Interventions
Endovascular interventions represent a less invasive approach to treating Peripheral Arterial Disease (PAD) compared to traditional open surgery. These procedures are performed through small punctures in the skin, typically in the groin or arm, using catheters and guidewires to access and treat the narrowed or blocked arteries [28]. Endovascular techniques are often preferred for their quicker recovery times and reduced procedural risks, making them suitable for a broader range of patients.
**A. Angioplasty:** Angioplasty, specifically percutaneous transluminal angioplasty (PTA), involves inserting a catheter with a balloon at its tip into the narrowed artery. The balloon is then inflated to compress the plaque against the artery walls, thereby widening the vessel and improving blood flow [29]. Angioplasty can effectively alleviate symptoms like leg pain and promote wound healing [30].
**B. Stenting:** Following angioplasty, a stent—a small, expandable mesh tube—is often deployed to keep the artery open and prevent it from narrowing again [31]. There are two main types of stents used in PAD: bare-metal stents (BMS) and drug-eluting stents (DES). DES are coated with medication that is slowly released to inhibit cell growth and reduce the risk of restenosis (re-narrowing of the artery) [32]. While BMS provide structural support, DES have shown superior long-term patency rates in certain arterial segments [33].
**C. Atherectomy:** Atherectomy is a procedure that involves removing plaque from the inside of an artery using a specialized catheter with a cutting or ablating device [31]. This technique is particularly useful for treating calcified lesions that may not respond well to balloon angioplasty alone. By physically removing plaque, atherectomy aims to restore luminal patency and improve blood flow.
**D. Drug-Coated Balloons (DCB):** Drug-coated balloons combine the mechanical dilation of angioplasty with the localized delivery of an antiproliferative drug, typically paclitaxel. The drug is transferred to the vessel wall during balloon inflation, aiming to prevent restenosis without leaving a permanent implant like a stent [34]. DCBs have demonstrated efficacy in improving patency rates, especially in femoropopliteal arteries [35].
**E. Advantages and Disadvantages of Endovascular Approaches:**
| Feature | Advantages | Disadvantages | | :--- | :--- | :--- | | **Invasiveness** | Minimally invasive, smaller incisions, reduced pain | May not be suitable for all lesion types (e.g., very long or heavily calcified occlusions) | | **Recovery** | Shorter hospital stays, faster recovery times, quicker return to normal activities | Risk of re-stenosis (re-narrowing) over time, requiring repeat procedures | | **Complications** | Lower risk of major complications compared to open surgery (e.g., infection, bleeding) | Potential for arterial dissection, perforation, or distal embolization; radiation exposure | | **Patient Suitability** | Suitable for elderly or frail patients, and those with significant comorbidities who may not tolerate open surgery | Durability may be less than open surgical bypass for certain complex lesions; long-term outcomes can vary depending on lesion characteristics and patient risk factors |
VI. Surgical Interventions
For patients with severe Peripheral Arterial Disease (PAD) where lifestyle modifications, medical management, and endovascular interventions are insufficient or not feasible, surgical interventions become necessary. These procedures are generally more invasive but can offer durable solutions for complex or extensive arterial blockages, particularly in cases of limb-threatening ischemia [36].
**A. Bypass Surgery:** Bypass surgery involves creating a new pathway for blood to flow around a blocked or severely narrowed artery. A healthy blood vessel, either a vein from the patient's own body (autologous vein graft) or a synthetic graft, is used to reroute blood flow from above the blockage to below it [37, 38]. This procedure is highly effective in restoring blood flow to the affected limb, alleviating symptoms, and preventing limb loss [39]. Bypass surgery is often considered for long or complex blockages that are not amenable to endovascular repair.
**B. Endarterectomy:** Endarterectomy is a surgical procedure designed to remove plaque buildup directly from the inner lining of an artery [40]. The surgeon makes an incision in the artery and carefully removes the atherosclerotic plaque, thereby widening the vessel lumen and restoring blood flow [41]. This technique is commonly performed in the femoral artery but can be applied to other peripheral arteries as well. Endarterectomy is particularly useful for localized, significant blockages [42].
**C. Amputation (as a last resort):** Amputation is considered a last resort when all other treatment options have failed to restore adequate blood flow to the limb, and the tissue has become necrotic or severely infected, posing a threat to the patient's life or overall health [43]. The goal of amputation is to remove diseased tissue and prevent the spread of infection, while preserving as much functional limb as possible. This decision is made after careful consideration and extensive discussion with the patient and their healthcare team.
**D. Advantages and Disadvantages of Surgical Approaches:**
| Feature | Advantages | Disadvantages | | :--- | :--- | :--- | | **Efficacy** | Highly effective for severe and complex blockages, often providing durable revascularization | More invasive, requiring general anesthesia and longer hospital stays | | **Durability** | Can offer long-term patency, especially with autologous vein grafts | Higher risk of complications such as infection, bleeding, graft failure, and cardiac events | | **Patient Suitability** | Suitable for patients with extensive disease, failed endovascular interventions, or limb-threatening ischemia | Not suitable for all patients, especially those with significant comorbidities or poor overall health status due to increased surgical risk | | **Recovery** | Longer recovery period, requiring significant rehabilitation | Potential for chronic pain, nerve damage, and the need for repeat interventions or amputation in severe cases |
VII. Emerging Therapies and Future Directions
The landscape of Peripheral Arterial Disease (PAD) treatment is continuously evolving, with ongoing research exploring novel therapeutic strategies that aim to improve revascularization, reduce symptoms, and prevent limb loss. These emerging therapies offer hope for patients who may not be suitable for or have not responded to conventional treatments.
**A. Gene Therapy:** Gene therapy holds significant promise for PAD, particularly for severe cases such as critical limb ischemia (CLI). This approach involves introducing genetic material into the affected limbs to promote the growth of new blood vessels (angiogenesis) or to improve the function of existing ones [44, 45]. While no U.S.-authorized gene therapy for PAD currently exists in the United States, plasmid-based therapies are approved in other regions, demonstrating the potential of this innovative treatment modality [46]. Research is focused on delivering genes that encode for growth factors, which can stimulate collateral vessel formation and improve blood flow to ischemic tissues [47].
**B. Stem Cell Therapy:** Cell-based therapies, including stem cell therapy, are being investigated for their potential to repair damaged tissue and enhance revascularization in PAD patients. Stem cells, with their ability to differentiate into various cell types and release pro-angiogenic factors, can contribute to the formation of new blood vessels and improve tissue perfusion [48]. These advanced regenerative therapies are particularly relevant for patients with CLI and non-healing wounds, where conventional revascularization options are limited [49].
**C. Novel Pharmacological Agents:** Beyond traditional medications, new pharmacological agents are under investigation to address various aspects of PAD pathophysiology. This includes novel antiplatelet and anticoagulant strategies, as well as drugs targeting inflammation, oxidative stress, and metabolic pathways involved in atherosclerosis [50]. The development of dual antiplatelet therapy and other advanced medical therapies continues to refine the medical management of PAD, aiming for improved outcomes and reduced cardiovascular event risk [51].
VIII. Comparing Treatment Options
Choosing the most appropriate treatment for Peripheral Arterial Disease (PAD) is a complex decision that requires careful consideration of various factors, including the severity of the disease, the patient's overall health, comorbidities, lifestyle, and personal preferences. A shared decision-making approach between the patient and healthcare professionals is paramount to optimize outcomes [1].
**A. Efficacy and Durability:**
- **Lifestyle Modifications:** Highly effective in early-stage PAD and as an adjunct to all other treatments. Smoking cessation significantly slows disease progression, and supervised exercise programs improve walking distance and quality of life [12, 19]. Their durability depends on sustained patient adherence.
- **Medical Management:** Essential for controlling risk factors and preventing cardiovascular events. Antiplatelet agents and statins offer long-term benefits in reducing morbidity and mortality [22, 25]. Symptomatic relief from medications like cilostazol can be effective but may not alter disease progression [27].
- **Endovascular Interventions:** Provide effective revascularization for many lesions, particularly shorter and less complex ones. While generally less invasive, their durability can vary, with a risk of restenosis requiring repeat procedures, especially with bare-metal stents [32]. Drug-eluting stents and balloons have improved patency rates [33, 34].
- **Surgical Interventions:** Offer highly durable revascularization for complex and extensive blockages, often providing superior long-term patency compared to endovascular options for certain anatomies [36]. Bypass surgery, in particular, can provide lasting relief and limb salvage [39].
**B. Risks and Complications:**
- **Lifestyle Modifications:** Minimal risks, primarily related to potential overexertion if not properly supervised during exercise. The main challenge is adherence.
- **Medical Management:** Risks include side effects from medications (e.g., bleeding with antiplatelets, muscle pain with statins) and potential drug interactions. Regular monitoring is necessary [21].
- **Endovascular Interventions:** Risks include arterial dissection, perforation, distal embolization, infection, and radiation exposure. While generally lower than surgery, complications can occur [35]. Restenosis is a common long-term complication.
- **Surgical Interventions:** Higher risks due to their invasive nature, including significant bleeding, infection, graft failure, cardiac complications, and longer recovery times. Amputation, though a last resort, carries profound physical and psychological impacts [36].
**C. Patient Suitability (Age, Comorbidities, Disease Severity):**
- **Lifestyle Modifications:** Suitable for all PAD patients, especially crucial for early-stage disease and as foundational therapy.
- **Medical Management:** Appropriate for all PAD patients to manage risk factors and symptoms. The specific regimen is tailored to individual comorbidities.
- **Endovascular Interventions:** Often preferred for patients with less extensive disease, those who are not surgical candidates due to comorbidities, or as a first-line revascularization strategy due to its minimally invasive nature [28].
- **Surgical Interventions:** Reserved for patients with severe PAD, limb-threatening ischemia, extensive arterial disease not amenable to endovascular repair, or failed endovascular procedures. Patients must be fit enough to tolerate a major operation [36].
**D. Cost-Effectiveness:**
The cost-effectiveness of PAD treatments is a significant consideration. While lifestyle modifications and medical therapies are generally the most cost-effective initial approaches, the long-term costs associated with managing complications of untreated or inadequately treated PAD (e.g., hospitalizations, amputations) can be substantial. Endovascular procedures, while initially less expensive than surgery, may incur higher costs over time due to the need for repeat interventions. Surgical bypass, despite higher initial costs, can be more cost-effective in the long run for suitable patients due to its greater durability [36].
**E. Shared Decision-Making with Healthcare Professionals:**
Given the array of treatment options and their varying efficacies, risks, and durabilities, shared decision-making is critical. Patients should engage in thorough discussions with their vascular specialists, cardiologists, and primary care physicians to understand all available options, their potential benefits and harms, and how they align with their personal values and goals of care. This collaborative approach ensures that treatment plans are individualized and patient-centered [1].
IX. Conclusion
Peripheral Arterial Disease is a prevalent and progressive condition that necessitates a comprehensive and individualized treatment approach. From foundational lifestyle modifications and diligent medical management to advanced endovascular and surgical interventions, a spectrum of therapies is available to address the diverse needs of PAD patients. Emerging therapies, including gene and stem cell therapies, hold promise for future advancements, particularly for those with critical limb ischemia.
The optimal treatment strategy for PAD is rarely a one-size-fits-all solution. It requires a dynamic assessment of disease severity, patient comorbidities, and individual preferences, guided by evidence-based practices. The overarching goals remain consistent: to alleviate symptoms, prevent disease progression, reduce cardiovascular event risk, and ultimately enhance the patient's quality of life. Through a collaborative approach involving patients and their healthcare teams, tailored treatment plans can be developed to achieve the best possible outcomes.
X. Disclaimer
**Important Disclaimer:** This blog post is intended for informational and educational purposes only and does not constitute medical advice. The information provided herein should not be used for diagnosing or treating a health problem or disease, and it is not a substitute for professional medical care. If you have or suspect you have Peripheral Arterial Disease or any other medical condition, please consult with a qualified healthcare professional for diagnosis and treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this blog post.
References
[1] [Peripheral artery disease (PAD) - Diagnosis and treatment](https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/diagnosis-treatment/drc-20350563) [2] [Peripheral Artery Disease (PAD)](https://my.clevelandclinic.org/health/diseases/17357-peripheral-artery-disease-pad) [3] [Peripheral Arterial Disease - StatPearls - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK430745/) [4] [The Current U.S. Prevalence of Peripheral Arterial Disease](https://www.hmpgloballearningnetwork.com/site/vdm/current-us-prevalence-peripheral-arterial-disease) [5] [Epidemiology of peripheral artery disease](https://pubmed.ncbi.nlm.nih.gov/25908725/) [6] [Peripheral Artery Disease | PAD](https://medlineplus.gov/peripheralarterialdisease.html) [7] [Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment](https://www.aafp.org/pubs/afp/issues/2019/0315/p362.html) [8] [Peripheral Artery Disease (PAD) - UCSF : General Surgery](https://generalsurgery.ucsf.edu/condition/peripheral-artery-disease-pad) [9] [Peripheral Artery Disease - Treatment | NHLBI, NIH](https://www.nhlbi.nih.gov/health/peripheral-artery-disease/treatment) [10] [Symptoms, quality of life important to guide treatment for peripheral ...](https://newsroom.heart.org/news/symptoms-quality-of-life-important-to-guide-treatment-for-peripheral-artery-disease-pad) [11] [Advancing Peripheral Artery Disease Quality of Care and Outcomes ...](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001105) [12] [Prevention and Treatment of PAD](https://www.heart.org/en/health-topics/peripheral-artery-disease/prevention-and-treatment-of-pad) [13] [Smoking and Peripheral Artery Disease (PAD): What to Know](https://michiganvascularcenter.com/smoking-and-peripheral-artery-disease-pad/) [14] [Smoking and Peripheral Arterial Disease (PAD)](https://hcic.io/smoking-and-pad/) [15] [Smoking Cessation Improves Outcomes in Patients With ...](https://jamanetwork.com/journals/jamacardiology/fullarticle/2784940) [16] [Effectiveness of a Smoking Cessation Program for ...](https://www.sciencedirect.com/science/article/pii/S0735109710041847) [17] [Supervised Exercise Therapy for Peripheral Artery ...](https://www.heart.org/-/media/Files/Health-Topics/Peripheral-Artery-Disease/PAD-Webinars/Webinar-3-Exercise-in-PAD-slides.pdf?sc_lang=en) [18] [PAD EXERCISE TRAINING TOOLKIT](https://www.aacvpr.org/Portals/0/pad-exercise-training-toolkit_website_2020.pdf) [19] [Optimal Exercise Programs for Patients With Peripheral ...](https://www.ahajournals.org/doi/10.1161/CIR.0000000000000623) [20] [Peripheral Artery Disease (PAD)](https://my.clevelandclinic.org/health/diseases/17357-peripheral-artery-disease-pad) [21] [Evidence-Based Medical Management of Peripheral Artery Disease](https://www.ahajournals.org/doi/10.1161/ATVBAHA.119.312142) [22] [Antiplatelet Therapy Following Peripheral Arterial ...](https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.120.009727) [23] [Antithrombotic Strategies in Patients With PAD: Key Points](https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2024/08/27/15/49/antithrombotic-strategies-for) [24] [Statins and Peripheral Arterial Disease: A Narrative Review](https://pmc.ncbi.nlm.nih.gov/articles/PMC8645843/) [25] [Statins in Peripheral Artery Disease | Circulation](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.033092) [26] [Statin use in patients with peripheral arterial disease](https://www.sciencedirect.com/science/article/pii/S0741521416311429) [27] [Peripheral artery disease (PAD) - Diagnosis and treatment](https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/diagnosis-treatment/drc-20350563) [28] [Endovascular Intervention for Peripheral Artery Disease - PMC - NIH](https://pmc.ncbi.nlm.nih.gov/articles/PMC4504240/) [29] [Angioplasty: Procedure, Types & Recovery](https://my.clevelandclinic.org/health/treatments/22060-angioplasty) [30] [Peripheral Arterial Angioplasty](https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.peripheral-arterial-angioplasty.aa118416) [31] [Surgery For Peripheral Artery Disease: Angioplasty & Stents](https://www.webmd.com/heart-disease/surgery-peripheral-artery-disease) [32] [Efficacy of a Drug-Eluting Stent Versus Bare Metal ...](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059606) [33] [Efficacy of a Drug-Eluting Stent Versus Bare Metal ...](https://pubmed.ncbi.nlm.nih.gov/36254728/) [34] [Drug-eluting devices for lower limb peripheral arterial ...](https://eurointervention.pcronline.com/article/drug-eluting-devices-for-lower-limb-peripheral-arterial-disease) [35] [Combining a Drug-Coated Balloon and a Bare-Metal Stent](https://evtoday.com/articles/2018-sept-supplement/combining-a-drug-coated-balloon-and-a-bare-metal-stent-the-response-adapted-combination-therapy-react-strategy) [36] [Surgical Intervention for Peripheral Arterial Disease](https://www.ahajournals.org/doi/10.1161/circresaha.116.303504) [37] [Bypass surgery](https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/diagnosis-treatment/drc-20350563) [38] [Peripheral artery bypass - leg](https://medlineplus.gov/ency/article/007394.htm) [39] [Surgical Bypass](https://vascular.org/your-vascular-health/your-care-journey/treatments/surgical-bypass) [40] [Endarterectomy: Procedure, Types & Purpose](https://my.clevelandclinic.org/health/treatments/17312-pad-endarterectomy) [41] [Endarterectomy Surgery: What to Expect](https://www.upmc.com/services/heart-vascular/services/procedures/endarterectomy-surgery) [42] [Endarterectomy for Atherosclerosis & Peripheral Artery ...](https://www.aurorahealthcare.org/services/heart-vascular/services-treatments/vascular-services/peripheral-artery-disease-treatments/endarterectomy-for-atherosclerosis-and-peripheral-artery-disease) [43] [Treatment Options for Peripheral Arterial Disease (PAD)](https://ourheartdr.com/vascular-services/peripheral-arterial-disease-pad/treatment-options-for-pad/) [44] [Gene therapy for peripheral arterial disease - PMC - NIH](https://pmc.ncbi.nlm.nih.gov/articles/PMC6517203/) [45] [Gene Therapeutic Strategies for Peripheral Artery Disease ...](https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318902) [46] [Current and Novel Emerging Medical Therapies for Peripheral ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC10278215/) [47] [Gene therapy shows promise for severe cases of peripheral artery disease (PAD)](https://greaterpittsburghvascular.com/2024/10/23/5-new-treatments-for-peripheral-artery-disease/) [48] [New Technologies For The Treatment Of Peripheral Artery Disease](https://advancedmedicalgroupnj.com/new-technologies-for-the-treatment-of-peripheral-artery-disease/) [49] [The Latest Treatments for Peripheral Artery Disease (PAD)](https://washingtonvascular.com/the-latest-treatments-for-peripheral-artery-disease-pad/) [50] [New Treatments for PAD (2025)](https://cacvi.org/new-treatments-for-pad/) [51] [Stepping Into the Future of Care for Patients With ...](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.069449)